Lipolysis-induced iron release from diferric transferrin: Possible role of lipoprotein lipase in LDL oxidation

Journal of Lipid Research

Volumn 40, Issue 7, 1999, Pages 1347-1356

  Balagopalakrishna, Chavali ^a   Paka, Latha ^a   Pillarisetti, Sivaram ^a   Goldberg, Ira J ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

Atherosclerosis; Fatty acids; Lipoprotein lipase; Proteoglycans; Triglycerides

Indexed keywords

INTRALIPID; IRON; IRON 59; IRON BINDING PROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OXIDIZED LOW DENSITY LIPOPROTEIN; SODIUM CHLORIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFERRIN; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; AORTA; ARTICLE; ATHEROSCLEROSIS; CATTLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IRON KINETICS; LIPID OXIDATION; LIPOLYSIS; NONHUMAN; PH; PRIORITY JOURNAL;

ANIMALS; CATTLE; CELLS, CULTURED; HUMANS; HYDROGEN-ION CONCENTRATION; IRON; LIPOLYSIS; LIPOPROTEIN LIPASE; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; TRANSFERRIN; TRIGLYCERIDES;

EID: 0032800284     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Steinbrecher, U. P., S. Parthasharathy, D. S. Leake, J. L. Witztum, and D. Steinberg. 1984. Modification of low density lipoproteins by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipid. Proc. Natl. Acad. Sci. USA. 81: 3883-3887.
2. Heinecke, J. W., L. Baker, H. Rosen, and A. Chait. 1986. Superoxide mediated modification of low density lipoproteins by arterial smooth muscle cells. J. Clin. Invest. 77: 757-761.
3. Steinberg, D., S. Parthasarathy, T. E. Crew, J. C. Khoo, and J. L. Witztum. 1989. Beyond cholesterol: modification of low density lipoproteins that increases its atherogenicity. N. Engl. J. Med. 320: 915-924.
4. Heinecke, J. W., H. Rosen, and A. Chait. 1984. Iron and copper promote modification of low density lipoproteins by human arterial smooth muscle cells in culture. J. Clin. Invest. 74: 1890-1894.
5. Halliwell, B., and J. M. C. Gutteridge. 1990. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186: 1-85.
6. Frei, B., L. England, and B. N. Ames. 1989. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA. 86: 6377-6381.
7. Kunitake, S. T., M. R. Jarvis, R. L. Hamilton, and J. P. Kane. 1992. Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: Inhibition of oxidation of low density lipoproteins. Proc. Natl. Acad. Sci. USA. 89: 6993-6997.
8. Frei, B., R. Stocker, and B. N. Ames. 1988. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA. 85: 9748-9752.
9. Stocks, J., J. M. C. Gutteridge, R. J. Sharp, and T. L. Dormandy. 1974. The inhibition of lipid peroxidation by human serum and its relation to serum proteins and α-tocopherol. Clin. Sci. Mol. Med. 47: 223-233.
10. Gutteridge, J. M. C., and G. J. Quinlan. 1992. Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidizing proteins. Biochim. Biophys. Acta. 1159: 248-254.
11. Stocker, R., and B. Frei. 1991. Endogenous antioxidant defenses in human blood plasma. In Oxidative Stress: Oxidants and Antioxidants H. Sies, editor. Academic Press Limited, London. 213-243.
12. Yuan, X. M., W. L. Anders, A. G. Olsson, and U. T. Brunk. 1996. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis. Atherosclerosis. 124: 61-73.
13. Smith, C., M. J. Mitchinson, O. I. Aruoma, and B. Halliwell. 1992. Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem. J. 286: 901-905.
14. Swain, J., and J. M. Gutteridge. 1995. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Lett. 368: 513-515.
15. Pearson, T. A., H. Malmros, J. Dillman, N. Sternby, and R. H. Heptinstall. 1987. Atherosclerosis in hypercholesterolemic hare: comparison of coronary artery lesions induced by dietary cholesterol in the hare and the rabbit. Atherosclerosis. 63: 125-135.
16. Araujo, J. A., E. L. Romano, B. E. Brito, V. Parthe, M. Romano, M. Bracho, R. F. Montano, and J. Cardier. 1995. Iron overload augments the development of atherosclerotic lesions in rabbits. Arterioscler. Thromb. Vasc. Biol. 15: 1172-1180.
17. Pang, J. H., M. J. Jiang, Y. L. Chen, F. W. Wang, D. L. Wang, S. H. Chu, and L. Y. Chau. 1996. Increased ferritin gene expression in atherosclerotic lesions. J. Clin. Invest. 97: 2204-2212.
18. 2-macroglobulin. Atherosclerosis. 34: 391-405.
19. Stastny, J. J., E. Fosslien, and A. L. Robertson, Jr. 1986. Human aortic intima protein composition during initial stages of atherogenesis. Atherosclerosis. 60: 131-139.
20. Stastny, J. J., and E. Fosslien. 1992. Quantitative alteration of some aortic intima proteins in fatty streaks and fibro-fatty lesions. Exp. Mol. Pathol. 57: 205-214.
21. Stastny, J. J., A. L. Robertson, Jr., and E. Fosslien. 1986. Basic proteins in the human aortic intima: Non equilibrium two-dimensional electrophoretic analysis of tissue extracts. Exp. Mol. Pathol. 45: 279-286.
22. Renswoude, J. V., K. R. Bridges, J. B. Harford, and R. D. Klausner. 1982. Receptor-mediated endocytosis of transferrin and the uptake of Fe in K562 cells: identification of a non-lysosomal acidic compartment. Proc. Natl. Acad. Sci. USA. 79: 6186-6190.
23. Nunez, M. T., V. Gaete, J. A. Watkins, and J. Glass. 1990. Mobilization of iron from endocytic vesicles: the effects of acidification and reduction. J. Biol. Chem. 265: 6688-6692.
24. Sipe, D. M., and R. F. Murphy. 1991. Binding to cellular receptors results in increased iron release from transferrin at mildly acidic pH. J. Biol. Chem. 266: 8002-8007.
25. Liao, F., J. A. Berliner, M. Mehrabian, M. Navab, L. L. Demer, A. J. Lusis, and A. M. Fogelman. 1991. Minimally modified low density lipoprotein is biologically active in vivo in mice. J. Clin. Invest. 87: 2253-2257.
26. Saxena, U. L., D. Witte, and I. J. Goldberg. 1989. Release of endothelial lipoprotein lipase by plasma lipoproteins and fatty acids. J. Biol. Chem. 264: 4349-4355.
27. Lowry, O. H., N. J. Rosebrough, A. L. Farr. and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
28. Nilsson-Ehle, P., and M. C. Schotz. 1976. A stable radioactive substrate emulsion for assay of lipoprotein lipase. J. Lipid Res. 17: 536-541.
29. Sivaram, P., M. G. Klein, and I. J. Goldberg. 1992. Identification of heparin-releasable lipoprotein lipase binding protein from endothelial cells. J. Biol. Chem. 267: 16517-16522.
30. Stins, M. F., F. R. Maxfield, and I. J. Goldberg. 1992. Polarized binding of lipoprotein lipase to endothelial cells. Implication for physiological action. Arterioscler. Thromb. 12: 1437-1446.
31. Huebers, H., E. Huebers, S. Linck, and W. Rummel. 1977. A study of plasma transferrin in normal and iron deficient rats. In Proteins of Iron Metabolism. E. B. Brown, P. Aisen, J. Fielding, and R. R. Crichton, editors. Grune and Stratton, New York. 251-252.
32. Bali, P. K., O. Zak, and P. Aisen. 1991. A new role for the transferrin receptor in the release of iron from transferrin. Biochemistry. 30: 324-328.
33. Hatch, F. T., and R. S. Lees. 1968. Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 6: 1-68.
34. Uchiyama, M., and M. Mihara. 1978. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86: 271-278.
35. Kleinveld, H. A., A. H. J. Naber, A. F. H. Stalenhoef, and P. N. M. Demacker. 1993. Oxidation resistance, oxidation rate, and extent of oxidation of human low density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: studies in vitamin E deficient subjects. Free Radical Biol. Med. 15: 273-280.
36. Frei, B., L. England, and B. N. Ames. 1989. Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA. 86: 6377-6381.
37. Kunitake, S. T., M. R. Jarvis, R. L. Hamilton, and J. P. Kane. 1992. Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc. Natl. Acad. Sci. USA. 89: 6993-6997.
38. Frei, B., R. Stocker, and B. N. Ames. 1988. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc. Natl. Acad. Sci. USA. 85: 9748-9752.
39. Stocks, J., J. M. C. Gutteridge, R. J. Sharp, and T. L. Dormandy. 1974. The inhibition of lipid peroxidation by human serum and its relation to serum proteins and α-tocopherol. Clin. Sci. Mol. Med. 47: 223-233.
40. Pacht, E. R., and W. B. Davis. 1988. Role of transferrin and ceruloplasmin in antioxidant activity of lung epithelial lining fluid. J. Appl. Physiol. 64: 2092-2099.
41. Guyton, J. R., and K. F. Klemp. 1996. Development of the lipid-rich core in human atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 16: 4-11.
42. Williams, K. J., and I. Tabas. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15: 551-561.
43. Berliner, J. A., M. Navab, A. M. Fogelman, J. S. Frank, L. L. Demer, P. A. Edwards, A. D. Watson, and A. J. Lusis. 1995. Atherosclerosis: basic mechanisms, oxidation, inflammation, and genetics. Circulation. 91: 2488-2496.
44. Liao, F., J. A. Berliner, M. Mehrabian, M. Navab, L. L. Demer, A. J. Lusis, and A. M. Fogelman. 1991. Minimally modified low density lipoprotein is biologically active in vivo in mice. J. Clin. Invest. 87: 2253-2257.
45. Cushing, S. D., J. A. Berliner, and A. J. Valente. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87: 5134-5138.
46. Rajavashisth, T. B., A. Andalibi, M. C. Territo, J. A. Berliner, M. Navab, A. M. Fogelman, and A. J. Lusis. 1990. Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low-density lipoproteins. Nature. 344: 254-257.
47. Drake, T. A., K. Hannani, H. H. Fei, S. Lavi, and J. A. Berliner. 1991. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am. J. Pathol. 138:601-607.
48. Fox, P. L., G. M. Chisolm, and P. E. DiCorleto. 1987. Lipoprotein mediated inhibition of endothelial cell production of platelet-derived growth factor-like proteins depends on free radical lipid peroxidation. J. Biol. Chem. 262: 6046-6054.
49. Parhami, F., Z. T. Fang, B. Yang, A. M. Fogelman, and J. A. Berliner. 1995. Stimulation of Gs and inhibition of Gi protein functions by minimally oxidized LDL. Arterioscler. Thromb. Vasc. Biol. 15: 2019-2024.
50. Lamb, D. J., and D. S. Leake. 1994. Iron released from transferrin at acidic pH can catalyze the oxidation of low density lipoprotein. FEBS Lett. 352: 15-18.
51. Heinecke, J. W., H. Rosen, L. A. Suzuki, and A. Chait. 1987. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 232: 10098-10103.
52. Sparrow, C. P., and J. Olszewski. 1993. Cellular oxidation of lipoproteins is caused by thiol production in media containing transition metal ions. J. Lipid Res. 34: 1219-1228.
53. Goldberg, I. J. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37: 693-707.
54. Ebenbichler, C. F., R. Kirchmair, C. Egger, and J. R. Patsch. 1995. Postprandial state and atherosclerosis. Curr. Opinion. Lipidol. 6: 286-290.
55. Karpe, F., G. Steiner, K. Uffelman, T. Olivecrona, and A. Hamsten. 1994. Postprandial lipoproteins and coronary atherosclerosis. Atherosclerosis. 106: 83-97.
56. Gronholdt, M. L., B. G. Nordestgaard, T. G. Nielssen, and H. Sillesen. 1996. Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins. Stroke. 27: 2166-2172.
57. Rutledge, J. C., M. W. Woo, A. A. Rezai, L. K. Curtiss, and I. J. Goldberg. 1997. Lipoprotein lipase increases lipoprotein binding to the arterial wall and increases endothelial layer permeability by formation of lipolysis products. Circ. Res. 80: 819-828.
58. Morgan, J., and D. S. Leake. 1995. Oxidation of low density lipoprotein by iron or copper at acidic pH. J. Lipid Res. 36: 2504-2512.
59. Peterson, J., B. E. Bihain, G. Bengtsson-Olivecrona, R. Deckelbaum, Y. A. Carpentier, and T. Olivecrona. 1990. Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport. Proc. Natl. Acad. Sci. USA. 87:909-913.
60. McLean, L. R., W. J. Larsen, and R. L. Jackson. 1986, Interaction of lipoprotein lipase with phospholipid vesicles: effect on protein and lipid structure. Biochemistry. 25: 873-878.
61. Loike, J. D., R. Silverstein, L. Cao, L. Solomon, J. Weitz, E. Haber, G. R. Matsueda, M. S. Bernatowicz, and S. C. Silverstein. 1993. Activated platelets form protected zones of adhesion on fibrinogen and fibronectin-coated surfaces. J. Cell. Biol. 121: 945-955.
62. Rice, W. G., and S. J. Weiss. 1990. Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science. 249: 178-181.
63. Weitz, J. I., A. J. Huang, S. L. Landman, S. C. Nicholson, and S. C. Silverstein. 1987. Elastase-mediated fibrinogenolysis by chemoattractant-stimulated neutrophils occurs in the presence of physiological concentrations of antiproteinases. J. Exp. Med. 166: 1836-1850.
64. Wright, S. D., and S. C. Silverstein. 1984. Phagocytosing macrophages exclude proteins from zones of contact with opsonized targets. Nature. 309: 359-361.